Ocuphire Pharma Results slide image

Ocuphire Pharma Results

North America & Caribbean (NAC) 2045 63 million 2030 57 million 51 million 2021 South & Central America (SACA) 2045 49 million 2030 40 million 32 million 2021 Diabetes is a Growing Global Health Epidemic Diabetes Cost Burden Over $900 Billion Dollars in Worldwide Health Expenditure Africa (AFR) 2045 2030 2021 55 million 33 million 24 million ↑ 24% increase 50% increase ↑ 134% increase World 2045 783 million 2030 643 million 537 million 2021 Ocuphire Source: International Diabetes Federation, Diabetes Atlas 10th Edition, 2021, https://diabetesatlas.org/atlas PHARMA 个 46% increase Europe (EUR) 2045 2030 2021 Western Pacific (WP) 260 million 2045 2030 238 million 2021 206 million South-East Asia (SEA) 2045 69 million 67 million 61 million 2030 2021 152 million 113 million 90 million 2021 2045 136 million 2030 95 million 73 million 个 个 Middle East & North Africa (MENA) 个 13% increase 27% increase 68% increase ↑ 87% increase 11
View entire presentation